Abstract
Two yttrium-90 (9Y) radiosynovectomy procedures were compared. One procedure, performed at the Royal Perth Rehabilitation Hospital (RPRH) required a shorter immobilisation time than that performed at the Sir Charles Gardiner Hospital (SCGH). There were no significant differences in outcome between the two procedures for the groups with inflammatory and osteoarthropathy. Thirty two patients (45 joints) with inflammatory arthropathy were treated (25 with rheumatoid arthritis, three with psoriatic arthritis, two with ankylosing spondylitis, and two with unspecified inflammatory arthropathy) and 40 patients (58 joints) with osteoarthropathy. A separate assessment of local lymph node spread in patients treated by the RPRH showed a minor spread of 9Y in one of 37 joints assessed. A marked improvement in the patient evaluation scores in the inflammatory arthropathy group at three months persisted at 12 months. Good lasting responses were more common in patients with inflammatory arthropathy with a normal joint or early radiological disease. A marked improvement in the pain and evaluation scores occurred at three months in the group with osteoarthropathy but had disappeared by six months after treatment.
Radiation synovectomy has been widely used to treat patients with persistently inflamed joints since the 1963 report of Ansell et al.l However, there continues to be a lack of consensus of the efficacy of this procedure in patients with inflammatory arthropathies2 3 and very little data on its relevance to patients with osteoarthropathies. 4 There have been few reports on the treatment of joints other than the knee, although with current imaging facilities and the use of iodinated water soluble contrast agents needles can be accurately placed in the joint space and radioisotopes instilled. The injection of larger joints such as the hip and shoulder are preferred, but smaller joints (elbows and ankles) can also be treated with this procedure. Immobilisation of the joint following the injection of yttrium-90 (90Y) is now considered to be essential to reduce the spread of the isotope to regional lymph nodes and the liver.5 6 Immobilisation of the joint with a long leg plaster cylinder applied prior to the procedure with a window cut for access adequately immobilises the joint but is time consuming to fit and cumbersome to wear. The clinical diagnosis, current drug treatment, reasons for the 90Y synovectomy, the number of previous aspirations and intra-articular injections of steroids in the previous 12 months and the response to the last intra-articular injection of steroids were recorded at the initial assessment. A radiograph of the joint to be injected was reviewed if available. The patient recorded on an analogue scale (0-100 mm) the degree of pain in the joint. The duration of morning stiffness (minutes), the pain free walking distance (metres), and standing time (minutes) over the previous week were recorded at the first visit. The tenderness score (range 0-3) of the joint to be injected was assessed by a clinical metrologist (BL) as described previously.8 At review the initial assessments were repeated and in addition the number of joint aspirations necessary since the 9Y injection and the patient's evaluation of the joint (l=good, 2=same, 3=worse) were recorded. RADIOLOGICAL 
ASSESSMENT
Radiographic changes in the inflammatory arthropathy and osteoarthropathy groups were classified as normal or early if there was persisting joint space, or advanced if there was no residual joint space.
GAMMA CAMERA SCANNING FOLLOWING INJECTION OF YTTRIUM-90
This was undertaken on the RPRH patients to assess the distribution of the isotope within the joint space and the extent of distribution outside the joint following the 9Y injection.9 Yttrium-90 (a pure beta (Ii) emitter) was imaged using Bremsstrahlung radiation. This is 'scattered' radiation arising from the interaction of particles with the tissue. The two patients who were not using a non-steroidal anti-inflammatory drug (NSAID), 22 who were using one such drug and eight who were using two such drugs at the time of the injection. A second line antirheumatic drug was being used by 27 of 32 patients with inflammatory arthropathy at the start of the study. The procedure was performed in the inflammatory arthropathy joints because of pain in eight, an effusion in seven, and pain and an effusion in 30 patients. In the previous 12 months less than two or more than three intra-articular steroidal injections had been performed in 30 and 15 joints, respectively. The response to the intra-articular steroid injection was rated as good in 34% of patients. Table 3 shows that radiographs were not available for review in 12 joints, were normal in seven joints, showed early changes in 13 joints, and advanced changes in 13. One patient had surgery on both injected joints within 12 months of the 9Y and intra-articular steroid injection. The osteoarthropathy group included 10 patients who were not using NSAIDs, 27 who were using one NSAID, and three who were using two NSAIDs at the time of the procedure. The procedure was undertaken in all osteoarthropathy joints as a result of pain. In half the joints a significant effusion was also present. An intra-articular steroid injection had been performed less than two or more than three times in 45 and 13 joints, respectively, in the 12 months prior to the 9Y injection and intraarticular steroid injection. Radiograph(s) obtained prior to the procedure were not available for assessment in four joints, were normal in one joint, and showed early or advanced changes in 20 and 33 joints, respectively. Four patients had surgery on the injected joint within 12 months of the 90Y and an intraarticular steroid injection.
The patients with inflammatory arthropathy had a significant improvement in pain, joint tenderness, and overall patient evaluation score at most time points following the procedure (table 2) . The overall evaluation of the procedure showed that at 12 months a good result occurred in 26 joints (74%), a poor result in eight joints (23%), and no change in one joint (3%). Patients with a normal joint or early radiological disease had a better response to 9Y than those with advanced radiological damage (table 3) . The results for the osteoarthropathy group show a different profile (table 2) . There was a marked improvement in pain at the six and 12 week assessments, but this had disappeared by later assessments. There was little change in the joint tenderness scores and the change in the patient evaluation scores was similar to the pain scores. The procedure in the osteoarthropathy group was rated as good for 20 joints (43%), poor for 20 joints (43%), and there was no change in seven joints (14%) at 12 months. The radiographic damage at onset in the patients with osteoarthropathy did not influence the reports of a good or poor response at 12 months (table 3). The duration of morning stiffness, the pain free walking distance, and the standing time did not change significantly in either the inflammatory arthropathy or osteoarthropathy groups at any of the follow up assessments compared with the initial assessment. Gammacamera scanning of 37 joints injected at the RPRH showed only minimal lymph node activity from one joint (2 7% The continuing evidence is compelling that 90Y has an established place in the management of persistent inflammatory synovitis of the knee. This study suggests that a short time of immobilisation after 90Y injection is adequate to ensure a good prolonged improvement in joint symptoms. Further studies are required to define its role in synovitis of other joints, the osteoarthritic joint, and the benefits or side effects of repeated injections.
